The following Structured Product Label (SPL) was submitted to the FDA by Health Department, Oklahoma State for the product Banophen (NDC 83112-555). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - when using, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
marked drowsiness may occur
avoid alcoholic beverages
alcohol, sedatives, and tranquilizers may increase drowsiness
use caution when driving a motor vehicle or operating machinery
excitability may occur, especially in children
* Please review the disclaimer below.
